158 related articles for article (PubMed ID: 18565966)
61. Recombinant activated factor VII effectively reverses the anticoagulant effects of heparin, enoxaparin, fondaparinux, argatroban, and bivalirudin ex vivo as measured using thromboelastography.
Young G; Yonekawa KE; Nakagawa PA; Blain RC; Lovejoy AE; Nugent DJ
Blood Coagul Fibrinolysis; 2007 Sep; 18(6):547-53. PubMed ID: 17762530
[TBL] [Abstract][Full Text] [Related]
62. Effect of Hemodilution In Vitro with Hydroxyethyl Starch on Hemostasis.
Jin S; Yu G; Hou R; Shen B; Jiang H
Med Sci Monit; 2017 May; 23():2189-2197. PubMed ID: 28481865
[TBL] [Abstract][Full Text] [Related]
63. An experimental study on the effect of plasma expanders on blood coagulability.
Narita T; Matsumoto I; Kumazawa T; Ikezono E
Bull Tokyo Med Dent Univ; 1979 Mar; 26(1):25-32. PubMed ID: 85502
[TBL] [Abstract][Full Text] [Related]
64. Reversal of apixaban induced alterations in haemostasis by different coagulation factor concentrates in patients after hip or knee replacement surgery.
Schmidt K; Krüger K; Langer E; Schmutzler M; Johnen E; Wernecke KD; von Heymann C; Körber MK
Blood Transfus; 2019 Mar; 17(2):157-162. PubMed ID: 29757137
[TBL] [Abstract][Full Text] [Related]
65. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery.
Haisch G; Boldt J; Krebs C; Kumle B; Suttner S; Schulz A
Anesth Analg; 2001 Mar; 92(3):565-71. PubMed ID: 11226079
[TBL] [Abstract][Full Text] [Related]
66. Acid-base changes caused by 5% albumin versus 6% hydroxyethyl starch solution in patients undergoing acute normovolemic hemodilution: a randomized prospective study.
Rehm M; Orth V; Scheingraber S; Kreimeier U; Brechtelsbauer H; Finsterer U
Anesthesiology; 2000 Nov; 93(5):1174-83. PubMed ID: 11046202
[TBL] [Abstract][Full Text] [Related]
67. Primary hemostasis in hemodilution--2) Infusion solutions.
Dietrich G; Orth D; Haupt W; Kretschmer V
Infusionstherapie; 1990 Aug; 17(4):214-6. PubMed ID: 1698720
[TBL] [Abstract][Full Text] [Related]
68. Recombinant factor VIIa reduces bleeding after blunt liver injury in coagulopathic, hypofibrinogenaemic pigs.
Grottke O; Braunschweig T; Zimmermann L; Kopp R; Lauritzen B; Coburn M; Tolba R; Rossaint R
Br J Anaesth; 2010 Dec; 105(6):789-97. PubMed ID: 20926476
[TBL] [Abstract][Full Text] [Related]
69. A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
Tomokiyo K; Nakatomi Y; Araki T; Teshima K; Nakano H; Nakagaki T; Miyamoto S; Funatsu A; Iwanaga S
Vox Sang; 2003 Nov; 85(4):290-9. PubMed ID: 14633255
[TBL] [Abstract][Full Text] [Related]
70. Optimizing thrombelastography (TEG) assay conditions to monitor rFVIIa (NovoSeven) therapy in haemophilia A patients.
Viuff D; Andersen S; Sørensen BB; Lethagen S
Thromb Res; 2010 Aug; 126(2):144-9. PubMed ID: 20542542
[TBL] [Abstract][Full Text] [Related]
71. Recombinant activated factor VII (rFVIIa, NovoSeven).
Agarwal MB; Patnaik M
J Assoc Physicians India; 2005 Aug; 53():717-20. PubMed ID: 16398083
[TBL] [Abstract][Full Text] [Related]
72. Neonatal thrombocytopenia: Thrombin generation in presence of reduced platelet counts and effects of rFVIIa in cord blood.
Haidl H; Pohl S; Leschnik B; Gallistl S; Muntean W; Schlagenhauf A
Sci Rep; 2019 May; 9(1):8014. PubMed ID: 31142810
[TBL] [Abstract][Full Text] [Related]
73. Thrombelastogram reveals hypercoagulability after administration of gelatin solution.
Karoutsos S; Nathan N; Lahrimi A; Grouille D; Feiss P; Cox DJ
Br J Anaesth; 1999 Feb; 82(2):175-7. PubMed ID: 10364989
[TBL] [Abstract][Full Text] [Related]
74. Factor VIIa analogue (V158D/E296V/M298Q-FVIIa) normalises clot formation in whole blood from patients with severe haemophilia A.
Sørensen B; Persson E; Ingerslev J
Br J Haematol; 2007 Apr; 137(2):158-65. PubMed ID: 17391496
[TBL] [Abstract][Full Text] [Related]
75. The effects of in vitro hemodilution with gelatin, hydroxyethyl starch, and lactated Ringer's solution on markers of coagulation: an analysis using SONOCLOT.
Konrad C; Markl T; Schuepfer G; Gerber H; Tschopp M
Anesth Analg; 1999 Mar; 88(3):483-8. PubMed ID: 10071991
[TBL] [Abstract][Full Text] [Related]
76. Are lactated Ringer's solution and normal saline solution equal with regard to coagulation?
Boldt J; Haisch G; Suttner S; Kumle B; Schellhase F
Anesth Analg; 2002 Feb; 94(2):378-84, table of contents. PubMed ID: 11812703
[TBL] [Abstract][Full Text] [Related]
77. Recombinant factor VIIa in trauma patients with the 'triad of death'.
Mitra B; Cameron PA; Parr MJ; Phillips L
Injury; 2012 Sep; 43(9):1409-14. PubMed ID: 21345431
[TBL] [Abstract][Full Text] [Related]
78. Survival time in severe hemorrhagic shock after perioperative hemodilution is longer with PEG-conjugated human serum albumin than with HES 130/0.4: a microvascular perspective.
Martini J; Cabrales P; K A; Acharya SA; Intaglietta M; Tsai AG
Crit Care; 2008; 12(2):R54. PubMed ID: 18423033
[TBL] [Abstract][Full Text] [Related]
79. Antithrombin efficiency is maintained in vitro in human plasma following dilution with hydroxyethyl starches.
Nielsen VG
Blood Coagul Fibrinolysis; 2005 Jul; 16(5):319-22. PubMed ID: 15970714
[TBL] [Abstract][Full Text] [Related]
80. Influence of low molecular weight hydroxyethyl starch (HES 40/0.5-0.55) on hemostasis and hemorheology.
Treib J; Haass A; Pindur G; Grauer MT; Seyfert UT; Treib W; Wenzel E; Schimrigk K
Haemostasis; 1996; 26(5):258-65. PubMed ID: 8894656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
